Novalaka won first place from the 120 medical start-ups that presented. NovaLaka is an innovator of slow release drug delivery systems for the transmucosal drug delivery market. Their flagship product, EnGel, which was pitched at the Global Pitch event, is based purely on the unique formulation of bio-adhesive and biodegradable polymers, in the revolutionary way targets vaginal dryness. NovaLaka is a Jerusalem startup associated with the AtoBe accelerator of Azrieli College of Engineering.
For more information, see: